GeneDx Holdings Corp (NASDAQ: WGS) open the trading on Thursday, with a bit cautious approach as it glided -7.86% to $56.00, before settling in for the price of $60.78 at the close. Taking a more long-term approach, WGS posted a 52-week range of $1.16-$61.41.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
The Healthcare Sector giants’ yearly sales growth during the last 5-year period was 5.08%. Nevertheless, stock’s Earnings Per Share (EPS) this year is 76.59%. This publicly-traded company’s shares outstanding now amounts to $25.98 million, simultaneously with a float of $19.13 million. The organization now has a market capitalization sitting at $1.51 billion. At the time of writing, stock’s 50-day Moving Average stood at $40.32, while the 200-day Moving Average is $22.09.
GeneDx Holdings Corp (WGS) Ownership Facts and Figures
Sometimes it helps to make our mind if we keep our tabs on how bigger investors are working with the stock of the Health Information Services industry. GeneDx Holdings Corp’s current insider ownership accounts for 28.96%, in contrast to 58.65% institutional ownership. Preceding that transaction, on Sep 16 ’24, Company’s Chief Executive Officer sold 10,501 for 37.59, making the whole transaction’s value amount to 394,733. This particular insider is now the holder of 103,706 in total.
GeneDx Holdings Corp (WGS) Earnings and Revenue Records
GeneDx Holdings Corp’s EPS increase for this current 12-month fiscal period is 76.59% and is forecasted to reach -0.04 in the upcoming year.
GeneDx Holdings Corp (NASDAQ: WGS) Trading Performance Indicators
Let’s observe the current performance indicators for GeneDx Holdings Corp (WGS). It’s Quick Ratio in the last reported quarter now stands at 2.22. The Stock has managed to achieve an average true range (ATR) of 3.47. Another valuable indicator worth pondering is a publicly-traded company’s price to sales ratio for trailing twelve months, which is currently 6.19.
In the same vein, WGS’s Diluted EPS (Earnings per Share) trailing twelve months is recorded -4.50, a figure that is expected to reach -0.26 in the next quarter, and analysts are predicting that it will be -0.04 at the market close of one year from today.
Technical Analysis of GeneDx Holdings Corp (WGS)
[GeneDx Holdings Corp, WGS] recent stats showed that its last 5-days Average volume was superior the volume it posted in the year-ago period. During the previous 9 days, stock’s Stochastic %D was recorded 80.57% While, its Average True Range was 3.80.
Raw Stochastic average of GeneDx Holdings Corp (WGS) in the period of the previous 100 days is set at 85.95%, which indicates a major rise in contrast to 72.36% during the last 2-weeks. If we go through the volatility metrics of the stock, In the past 14-days, Company’s historic volatility was 60.66% that was lower than 74.50% volatility it exhibited in the past 100-days period.
